The findings, Semaglutide and Tirzepatide reduce alcohol consumption in individuals with obesity, were reported in Scientific Reports.
Thondam SK, Cuthbertson DJ, Wilding JPH (2020) The influence of glucose-dependent insulinotropic polypeptide (GIP) on human adipose tissue and fat metabolism: implications for obesity, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
Investigated for roles in tissue regeneration and musculoskeletal recovery
However, selective NTS GLP-1R knockout attenuated chronic liraglutide-induced weight loss, while AP lesioning did not (84, 124)
They can evaluate whether a dose adjustment, medication switch, or adjunctive therapy is appropriate
(STEP 1: once-weekly semaglutide in adults with overweight or obesity.) Walker RF